Liver Res 5:4552 Woodhead JL, Yang K, Oldach D, MacLauchlin C, Fernandes P, Watkins PB et al (2019) Analyzing the mechanisms behind macrolide antibiotic-induced liver injury using quantitative systems toxicology modeling
Where and how it is initiated in the cell remained unclear
Final Thoughts GLP-1 medications are transforming diabetes and weight management in 2026, but dialysis patients require specialized care and close monitoring
Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website
Autophagy 19 , 388400 (2023)